Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rishi Razdan

Vascular & Interventional Radiology Jacksonville, FL Medical Doctor

NPI 1003026329 CMS profile 45231

2416 Dunn Ave, Jacksonville, FL 32218

Open in the dashboard

General payments

$378,207

444 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$87,077 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Rishi Razdan of Jacksonville, FL is reported in the CMS Open Payments database as having received $378,207 across 444 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $87,077 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,181 21
2024 General $106,441 105
2023 General $87,658 114
2022 General $79,673 113
2021 General $71,106 80
2020 General $19,983 8
2019 General $164 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rishi Razdan
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Rishi Razdan were reported at $13,181. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Rishi Razdan Vascular & Interventional Radiology median Middle half National median
2019 $164 $422 $125–$1,555 $163
2020 $19,983 $200 $68–$652 $114
2021 $71,106 $280 $99–$866 $132
2022 $79,673 $433 $137–$1,497 $149
2023 $87,658 $506 $152–$2,019 $160
2024 $106,441 $556 $175–$1,930 $164
2025 $13,181 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $348,247 392 payments
  2. Medtronic Vascular, Inc. $17,544 5 payments
  3. Merit Medical Systems Inc $7,877 10 payments
  4. Avenu Medical Inc. $2,427 2 payments
  5. Mozarc Medical US LLC $1,096 5 payments
  6. Bard Peripheral Vascular, Inc. $226 12 payments
  7. Sirtex Medical Inc $166 2 payments
  8. Terumo Medical Corporation $132 2 payments
  9. Nevro Corp. $118 1 payment
  10. Philips Electronics North America Corporation $111 2 payments
  11. Other $264 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $279,850 60 payments
  2. Consulting Fee $46,779 18 payments
  3. Travel and Lodging $36,910 117 payments
  4. Food and Beverage $14,668 249 payments
Products named General payments · program years 2019–2025
  1. ELLIPSYS VASCULAR ACCESS SYSTEM $250,868 258 payments
  2. Ellipsys Catheters $69,618 75 payments
  3. Ellipsys Catheters $19,971 7 payments
  4. Wrapsody Stent Graft $7,191 7 payments
  5. IN.PACT AV $5,315 3 payments
  6. HawkOne $4,548 2 payments
  7. TurboHawk $2,340 33 payments
  8. PALINDROME $923 3 payments
  9. IN.PACT Admiral $206 2 payments
  10. ARGYLE $173 2 payments
  11. Other $1,291 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

404

Median for Interventional Radiology: 38

Drug cost

$8,795

Median for Interventional Radiology: $333

Branded share of claims

42.8%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 11 $6,447
Clopidogrel Clopidogrel Bisulfate Brand 122 $1,493
Cephalexin Generic 126 $376
Mupirocin Generic 28 $194
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 40 $147
Prednisone Generic 63 $77
Doxycycline Hyclate Generic 14 $62

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$195,762

Medicare's payments for the services billed

Medicare patients

358

Average age 65

Services billed

1,885

168 women, 190 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 75%
Diabetes 71%
Heart failure 65%
Ischemic heart disease 57%
Arthritis 43%
Atrial fibrillation 36%
COPD 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

444 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record